Stents Peripheral

Gore Tigris Vascular Stent, Health Canada approval, PAD, peripheral artery disease
News | Stents Peripheral | March 16, 2017

March 16, 2017 — W. L. Gore & Associates Inc. recently announced the Health Canada approval of the Gore Tigris...

TOBA II BTK clinical trial, Intact Vascular, Tack Endovascular System, CLI, critical limb ischemia, first patient treated
News | Stents Peripheral | March 02, 2017

March 2, 2017 — Intact Vascular Inc. announced in February that its Tack Optimized Balloon Angioplasty II Below the...

Biotronik, Pulsar-18 bare metal self-expanding stent, BMS SE, BIOFLEX PEACE trial, 12-month results, VEITHsymposium 2016
News | Stents Peripheral | December 13, 2016

December 13, 2016 — Biotronik announced the presentation of data confirming the efficacy of the Pulsar-18...

LimFlow System, critical limb ischemia, CLI, CE Mark
News | Stents Peripheral | December 08, 2016

December 8, 2016 — LimFlow SA announced in November that it received the CE Mark for its fully percutaneous LimFlow...

TCT 2016, TCT.16, main arena, late breaking trials
Feature | Cath Lab | September 28, 2016

September 28, 2016 — The Cardiovascular Research Foundation (CRF) included 11 late-breaking trials and 16 first...

Absorb, bioresorbable stent, FDA approval, FDA approves, FDA clears, most popular content, most popular stories, DAIC

The FDA clearance of the first bioresorbable stent, the Abbott Absorb, the first week of July has been the most popular story so far for all of 2016. It is the first fully dissolving stent approved for the U.S. market and many experts say this technology could be a paradigm shift in coronary and peripheral therapies in the coming years as the technology improves. 

Feature | August 05, 2016 | Dave Fornell

 

August 5, 2016 — Here are the top 20 most popular current content on the Diagnostic and Interventional...

Gore, Tigris stent, fluoropolymer nitinol stent, peripheral artery disease

The Gore Tigris is a dual-component stent with a unique fluoropolymer / nitinol design.

Technology | Stents Peripheral | August 02, 2016

August 2, 2016 —The U.S. Food and Drug Administration (FDA) granted market clearance for W. L. Gore & Associates...

Intact Vascular, TOBA III clinical study, Europe, Tack Endovascular System, peripheral artery disease, PAD
News | Peripheral Arterial Disease (PAD) | June 07, 2016

June 7, 2016 — Intact Vascular Inc. announced that its Tack Optimized Balloon Angioplasty III (TOBA III)...

Technology | Stents Peripheral | April 27, 2016

April 27, 2016 — Veniti Inc. announced the first successful treatment with the Vici Verto Venous Stent System of a...

PinnacleHealth Cardiovascular Institute, TOBA II study, first patient, Tack Endovascular System, PAD
News | Peripheral Arterial Disease (PAD) | March 22, 2016

March 22, 2016 — PinnacleHealth CardioVascular Institute enrolled the first patient in Pennsylvania into the TOBA II...

Boston Scientific, Eluvia vascular stent system, CE Mark, peripheral artery disease
News | Stents Peripheral | March 17, 2016

March 17, 2016 — Boston Scientific announced in late February that the Eluvia Drug-Eluting Vascular Stent System...

Intact Vascular, Tack Endovascular System

The Intact Vascular Tack Endovascular System is designed to spot stent dissections with a short, self-expanding 6 mm long stent that can expand to vessel diameters between 2.5-6 mm, so exact sizing is not needed.

Feature | Peripheral Arterial Disease (PAD) | February 22, 2016 | Dave Fornell

It is estimated that more than 10 million people in the United States are affected by...

Biotronik, Maquet, partnership, peripheral vascular devices, U.S. market, Astron self-expanding iliac stent
Technology | Stents Peripheral | February 17, 2016

February 17, 2016 — Biotronik announced a partnership with Maquet Medical Systems USA to distribute Biotronik...

Stentys, commercialization, BTK stent, below-the-knee arteries
News | Stents Peripheral | February 08, 2016

February 8, 2016 — Stentys announced the first distribution agreements for its...

Overlay Init